decitabine,venetoclax,gbt021601,quizartinib
global blood therapeutics,Abbvie,roche
[]
#gbt601 (aka gbt021601), a haemoglobin o2 affinity modifier, improved hb, lowered hemolytic markers, improved point of sickling (pos) on o2 gradient ektacytometry in phase 1 study of scd patients
#eha2022
brown c, et al. hemasphere, 2022;6(s3):s268 
blood doctor finding new treatments for #SickleCell #Thalassemia #PKdeficiency #G6PD #CDA #HS #HE/#HPP, @UofT_DoM @ihpmeuoft also @MSF Tweets are my own